Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Verso Corporation (VRS) Stacks Up Against Its Peers

Page 1 of 2

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over the 12-month period ending November 21, while more than 51% of the constituents of the index underperformed the benchmark. Hence, a random stock picking process will most likely lead to disappointment. At the same time, the 30 most favored mid-cap stocks by the best performing hedge funds monitored by Insider Monkey generated a return of 18% over the same time span. Of course, hedge funds do make wrong bets on some occasions and these get disproportionately publicized on financial media, but piggybacking their moves can beat the broader market on average. That’s why we are going to go over recent hedge fund activity in Verso Corporation (NYSE:VRS).

Is Verso Corporation (NYSE:VRS) a worthy investment now? Investors who are in the know are genuinely betting on the stock. The number of bullish hedge fund positions that are disclosed in regulatory 13F filings increased by 17 in recent months. There were no hedge funds in our database with VRS holdings at the end of the second quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP), Daqo New Energy Corp (NYSE:DQ), and New Home Company Inc (NYSE:NWHM) to gather more data points.

Follow Verso Corp (CVE:VRS)
Trade (CVE:VRS) Now!

We follow over 700 hedge funds and other institutional investors and by analyzing their quarterly 13F filings, we identify stocks that they are collectively bullish on and develop investment strategies based on this data. One strategy that outperformed the market over the last year involves selecting the 100 best-performing funds and identifying the 30 mid-cap stocks that they are collectively most bullish on. Over the past year, this strategy generated returns of 18%, topping the 8% gain registered by S&P 500 ETFs. We launched this strategy 2.5 years ago and it returned more than 39% since then, vs. 22% gain registered by the S&P 500 ETFs.

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,

lassedesignen/Shutterstock.com

How are hedge funds trading Verso Corporation (NYSE:VRS)?

As stated earlier, at the end of the third quarter, a total of 17 of the hedge funds tracked by Insider Monkey held long positions in this stock. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Howard Marks’s Oaktree Capital Management has the biggest position in Verso Corporation (NYSE:VRS), worth close to $20 million. Sitting at the No. 2 spot is Centerbridge Partners, led by Mark T. Gallogly, holding a $13 million position; 1.1% of its 13F portfolio is allocated to the stock. Other professional money managers that hold long positions contain Jonathan Kolatch’s Redwood Capital Management, Robert Henry Lynch’s Aristeia Capital and Clint Carlson’s Carlson Capital. We should note that Aristeia Capital is among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2